Global Dermatology Diagnostic Devices Market Segmentation, By Diagnostic Device (Imaging Device, Dermatoscope, Microscope), Treatment Device (Electrosurgical, Cryotherapy, Laser), Type (Dermatoscopes, Imaging Equipment, Microscopes and Trichoscopes, Biopsy Devices, Others), Application (Skin Cancer, Others), End-User (Hospitals, Clinics, Others) – Industry Trends and Forecast to 2031.
Global Dermatology Diagnostic Devices Market Analysis
Growing consciousness among the individuals to look good in public, thereby resulting in the feeling of confidence and courage, has carved the way for the growth of innovations in the dermatology department. Growing number of product innovations by the major manufacturers has resulted in the availability of high grade and high quality dermatology diagnostic devices all around the globe.
Global Dermatology Diagnostic Devices Market Size
Global dermatology diagnostic devices market size was valued at USD 16.75 billion in 2023 and is projected to reach USD 44.86 billion by 2031, with a CAGR of 13.10% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Dermatology Diagnostic Devices Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Key Market Players
|
Agfa-Gevaert Group (Belgium), Carl Zeiss AG (Germany), MELA Sciences, Inc. (US), Hologic, Inc. (US), Illumina, Inc. (US), Spindletop Capital (US), Heine Optotechnik (Germany), GENERAL ELECTRIC COMPANY (US), Koninklijke Philips N.V. (Netherlands), Leica Microsystems (Germany), Bruker (US), Solta Medical (US), CANDELA CORPORATION (US), Ambicare Health (UK), Siemens Healthcare Private Limited (Germany), Welch Allyn (US), CANON MEDICAL SYSTEMS CORPORATION (Japan), Galderma laboratories (US), Michelson Diagnostics Inc. (UK) and Canfield Scientific, Inc. (US)
|
Dermatology Diagnostic Devices Market Definition
From the name itself, it is clear that dermatology diagnostic devices are the medical devices that are used to study the skin and diagnose it for any diseases including suggesting treatment alternatives. The dermatology diagnostic devices are efficient and effective in diagnosing skin diseases such as acne, pigmentation, skin cancer and psoriasis.
Dermatology Diagnostic Devices Market Dynamics
Drivers
- The rise in the prevalence of cancer
Surging prevalence of skin cancer coupled with other dermatological diseases all around the globe is one of the major factors responsible for fostering growth in the market value. According to Skin Cancer Foundation, more than 10,130 people die of melanoma every year in the United States.
- Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for tissue regeneration procedures is also bolstering the market growth rate.
- Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Moreover, stringent regulations imposed by the government on industries pertaining to the air pollution will also work in the favour of the market.
Additionally, surge in the personal disposable income level, introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices and presence of several pollutants such as polycyclic aromatic hydrocarbons, oxides and ultraviolet radiation causing damage to the skin, positively affect the market growth rate.
Opportunities
Furthermore, upsurge in the public-private funding for target research activities, increasing levels of air pollution, growing number of aesthetic procedures, increasing awareness regarding melanoma among patients and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, availability of devices for performing imaging techniques in the developing regions and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and high associated with the skin disorder treatments and diagnostic procedures are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, complications pertaining to the skin surgical procedures, competitive pricing by low-cost manufacturers, availability of low-cost substitutes and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This dermatology diagnostic devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dermatology diagnostic devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Dermatology Diagnostic Devices Market
COVID-19 has significantly and negatively impacted the market. The funding for research and development activities was significantly reduced and cut down. Non-essential business witnessed disruption in every department. Supply chain disruptions demoted the market demand and supply. Shifting focus towards the essential healthcare procedures during this phase put a halt on unnecessary operations. There was a huge postponement on the non-essential medical procedures. People grew more towards to online and home care treatments. All of this proved to be a bane for the market during pandemic.
Dermatology Diagnostic Devices Market Scope
The dermatology diagnostic devices market is segmented on the basis of diagnostic device, treatment device, type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Diagnostic device
- Imaging Device
- Dermatoscope
- Microscope
Treatment Device
- Electrosurgical
- Cryotherapy
- Laser
Type
- Dermatoscopes
- Imaging Equipment
- Microscopes and Trichoscopes
- Biopsy Devices
- Others
Application
- Skin Cancer
- Others
End-user
- Hospitals
- Clinics
- Others
Dermatology Diagnostic Devices Market Regional Analysis
The dermatology diagnostic devices market is analysed and market size insights and trends are provided by country, diagnostic device, treatment device, type, application and end-user as referenced above.
The countries covered in the dermatology diagnostic devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the dermatology diagnostic devices market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, growing number of processes pertaining to drug development, increasing incidences of skin disorders such as psoriasis and melanoma and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, rising prevalence of skin cancer and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Dermatology Diagnostic Devices Market Share
The dermatology diagnostic devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dermatology diagnostic devices market.
Dermatology Diagnostic Devices Market Leaders Operating in the Market Are:
- Agfa-Gevaert Group (Belgium)
- Carl Zeiss AG (Germany)
- MELA Sciences, Inc. (US)
- Hologic, Inc. (US)
- Illumina, Inc. (US)
- Spindletop Capital (US)
- Heine Optotechnik (Germany)
- GENERAL ELECTRIC COMPANY (US)
- Koninklijke Philips N.V. (Netherlands)
- Leica Microsystems (Germany)
- Bruker (US)
- Solta Medical (US)
- CANDELA CORPORATION (US)
- Ambicare Health (UK)
- Siemens Healthcare Private Limited (Germany)
- Welch Allyn (US)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Galderma laboratories (US)
- Michelson Diagnostics Inc. (UK)
- Canfield Scientific, Inc. (US)
Latest Development in Dermatology Diagnostic Devices Market
- In Jul 2020, Lancer Skincare announced the launch of its very first skincare exfoliating device, the Pro Polish Microdermabrasion Device. Pro Polish enhances the efficacy of the Lancer routine by delivering surface-layer microdermabrasion in a patented, handheld device.
- In Jan 2020, 3Derm Systems, Inc. (3Derm) announced that it was granted two FDA Breakthrough Device designations for 3DermSpot, an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.
SKU-